9.675
前日終値:
$9.20
開ける:
$9.38
24時間の取引高:
4,138
Relative Volume:
0.00
時価総額:
$688.65M
収益:
$133.62M
当期純損益:
$-177.37M
株価収益率:
-3.3478
EPS:
-2.89
ネットキャッシュフロー:
$23.50M
1週間 パフォーマンス:
+9.54%
1か月 パフォーマンス:
+15.01%
6か月 パフォーマンス:
-52.73%
1年 パフォーマンス:
-51.18%
Xencor Inc Stock (XNCR) Company Profile
XNCR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
XNCR
Xencor Inc
|
9.676 | 600.68M | 133.62M | -177.37M | 23.50M | -2.89 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.32 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.31 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
327.53 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
569.13 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.48 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-21 | 開始されました | William Blair | Outperform |
2024-12-12 | 開始されました | Wells Fargo | Overweight |
2024-12-02 | アップグレード | Piper Sandler | Neutral → Overweight |
2024-04-16 | 繰り返されました | BTIG Research | Buy |
2024-02-28 | ダウングレード | Piper Sandler | Overweight → Neutral |
2023-05-19 | 開始されました | BofA Securities | Buy |
2022-12-06 | 開始されました | Cowen | Outperform |
2022-10-13 | アップグレード | Raymond James | Outperform → Strong Buy |
2022-09-21 | 開始されました | JP Morgan | Overweight |
2022-07-06 | 再開されました | Canaccord Genuity | Buy |
2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
2022-01-21 | 開始されました | SMBC Nikko | Outperform |
2021-12-15 | 開始されました | H.C. Wainwright | Buy |
2021-10-15 | 再開されました | BTIG Research | Buy |
2021-02-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
2020-03-04 | 開始されました | Barclays | Underweight |
2020-02-25 | アップグレード | Guggenheim | Neutral → Buy |
2020-01-30 | 開始されました | RBC Capital Mkts | Outperform |
2019-11-20 | 再開されました | Guggenheim | Neutral |
2019-08-07 | ダウングレード | Guggenheim | Buy → Neutral |
2019-08-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2019-06-13 | 開始されました | Mizuho | Buy |
2019-04-12 | 開始されました | Guggenheim | Buy |
2019-03-27 | 開始されました | Berenberg | Buy |
2019-03-15 | 開始されました | Raymond James | Outperform |
2018-09-10 | 再開されました | BTIG Research | Buy |
2018-03-28 | 再開されました | Leerink Partners | Outperform |
2017-03-02 | 開始されました | Instinet | Neutral |
2017-03-02 | 繰り返されました | Wedbush | Outperform |
2016-10-04 | 開始されました | Piper Jaffray | Overweight |
2015-12-22 | 開始されました | Canaccord Genuity | Buy |
2015-08-05 | 繰り返されました | MLV & Co | Buy |
2015-02-12 | 繰り返されました | Oppenheimer | Outperform |
2015-01-28 | 繰り返されました | MLV & Co | Buy |
2014-07-11 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Xencor Inc (XNCR) 最新ニュース
Is Xencor Inc. a good long term investmentFree Investment Case Studies - Autocar Professional
What analysts say about Xencor Inc. stockConsistent high-yield stocks - Autocar Professional
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Arizona State Retirement System - Defense World
What drives Xencor Inc. stock priceFree Stock Market Query - Autocar Professional
Xencor Inc. Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com
Why Xencor Inc. stock attracts strong analyst attentionFree Access to Community - Newser
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Teacher Retirement System of Texas - Defense World
Where are the Opportunities in (XNCR) - news.stocktradersdaily.com
What risks could impact Xencor Inc. stock performanceVerified Return Tips - Newser
Principal Financial Group Inc. Grows Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact - TipRanks
[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Xencor Inc. stock performs during market volatilityFree Financial Group - Newser
What makes Xencor Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Fed. Circ. Won't Revisit Jepson Claim Ruling In Xencor IP Case - Law360
(XNCR) Investment Analysis - news.stocktradersdaily.com
Closing Figures Unveiled: Xencor Inc (XNCR) Drop -8.18, Closes at 8.31 - DWinneX
Rhumbline Advisers Has $1.74 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor (NASDAQ:XNCR) Shares Down 5.7% on Insider Selling - Defense World
(XNCR) On The My Stocks Page - news.stocktradersdaily.com
Xencor director Gustafson sells shares worth $27,595 - Investing.com Australia
Xencor director Montgomery sells shares worth $20,422 - Investing.com
Xencor Holds Annual Stockholders Meeting on June 12 - TipRanks
Xencor (NASDAQ:XNCR) Trading Up 6.3%Should You Buy? - MarketBeat
USPTO Tells Fed. Circ. Not To Review Ruling In Xencor Case - Law360
Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Shares Purchased by California State Teachers Retirement System - Defense World
Bank of America Corp DE Sells 585,930 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Squarepoint Ops LLC - Defense World
When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com
Xencor Inc (NASDAQ: XNCR) Jumps 2.45%: What Could Be On The Way Going Forward? - Stocksregister
Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside - DirectorsTalk Interviews
Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria
Xencor Inc (XNCR) 財務データ
収益
当期純利益
現金流量
EPS
Xencor Inc (XNCR) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
GUSTAFSON KURT A | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
20,183 |
GORMAN KEVIN CHARLES | Director |
Jun 16 '25 |
Sale |
9.22 |
3,173 |
29,255 |
18,905 |
Feigal Ellen | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
RANIERI RICHARD J | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
大文字化:
|
ボリューム (24 時間):